tinidazole has been researched along with Parasitemia in 2 studies
Tinidazole: A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections.
tinidazole : 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.
Parasitemia: The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " After sporozoite inoculation and blood-stage cure of initial parasitemia with chloroquine, rhesus macaques were treated on subsequent relapses with chloroquine in conjunction with test regimens of approved drugs." | 3.78 | Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances. ( Bennett, K; Deye, GA; Fracisco, S; Gettayacamin, M; Hansukjariya, P; Im-erbsin, R; Macareo, L; Magill, AJ; Ohrt, C; Rothstein, Y; Sattabongkot, J, 2012) |
| "Tinidazole is a 5-nitroimidazole approved in the USA for the treatment of indications including amoebiasis and giardiasis." | 2.78 | Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse. ( Cheah, PY; Lwin, KM; Macareo, L; Miller, RS; Nosten, F; Yuentrakul, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Macareo, L | 2 |
| Lwin, KM | 1 |
| Cheah, PY | 1 |
| Yuentrakul, P | 1 |
| Miller, RS | 1 |
| Nosten, F | 1 |
| Deye, GA | 1 |
| Gettayacamin, M | 1 |
| Hansukjariya, P | 1 |
| Im-erbsin, R | 1 |
| Sattabongkot, J | 1 |
| Rothstein, Y | 1 |
| Fracisco, S | 1 |
| Bennett, K | 1 |
| Magill, AJ | 1 |
| Ohrt, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax[NCT00811096] | Phase 2 | 20 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for tinidazole and Parasitemia
| Article | Year |
|---|---|
Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse.
Topics: Adult; Antimalarials; Chemoprevention; Chloroquine; Drug Therapy, Combination; Female; Humans; Malar | 2013 |
1 other study available for tinidazole and Parasitemia
| Article | Year |
|---|---|
Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.
Topics: Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Evaluation, Preclinical; Macaca mu | 2012 |